Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume $9.89 -0.57 (-5.45%) Closing price 07/24/2025 03:59 PM EasternExtended Trading$10.12 +0.23 (+2.33%) As of 07/24/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics Short Interest DataIndaptus Therapeutics (INDP) has a short interest of 29,900 shares, representing 5.22% of the float (the number of shares available for trading by the public). This marks a -96.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 31,914 shares to cover all short positions.Current Short Interest29,900 sharesPrevious Short Interest748,000 sharesChange Vs. Previous Month-96.00%Dollar Volume Sold Short$314.85 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2025Outstanding Shares570,000 sharesFloat Size572,700 sharesShort Percent of Float5.22%Today's Trading Volume5,228 sharesAverage Trading Volume31,914 sharesToday's Volume Vs. Average16% Short Selling Indaptus Therapeutics? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202529,900 shares $314.85 thousand -96.0%5.2%0.1 $10.53 6/15/2025748,000 shares $242.95 thousand -26.7%5.8%0.1 $0.32 5/31/20251,020,000 shares $343.33 thousand +1,157.7%7.9%1.5 $0.34 5/15/202581,100 shares $34.06 thousand -32.4%0.6%0.2 $0.42 4/30/2025119,900 shares $55.15 thousand -8.5%0.9%0.3 $0.46 4/15/2025131,100 shares $66.11 thousand -40.7%1.0%0.3 $0.50 3/31/2025221,200 shares $121.64 thousand +322.1%1.9%0.6 $0.55 3/15/202552,400 shares $42.19 thousand -10.0%0.5%0.1 $0.81 2/28/202558,200 shares $48.83 thousand -25.9%0.5%2.5 $0.84 2/15/202578,500 shares $62.72 thousand +102.8%0.7%3.1 $0.80 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202538,700 shares $35.22 thousand -41.7%0.4%1.6 $0.91 1/15/202566,400 shares $57.77 thousand -11.2%0.7%0.6 $0.87 12/31/202474,800 shares $62.99 thousand -19.1%0.8%0.7 $0.84 12/15/202492,500 shares $92.50 thousand +0.5%1.0%0.8 $1.00 11/30/202492,000 shares $93.84 thousand +8.2%1.1%0.8 $1.02 11/15/202485,000 shares $94.35 thousand -38.7%1.1%0.8 $1.11 10/31/2024138,700 shares $162.28 thousand +348.9%1.9%1.3 $1.17 10/15/202430,900 shares $39.24 thousand -9.7%0.4%0.3 $1.27 9/30/202434,200 shares $42.41 thousand +284.3%0.5%2.5 $1.24 9/15/20248,900 shares $13.44 thousand +140.5%0.1%0.7 $1.51 8/31/20243,700 shares $6.10 thousand -47.9%0.1%0.3 $1.65 8/15/20247,100 shares $11.86 thousand -12.4%0.1%0.4 $1.67 7/31/20248,100 shares $16.52 thousand -42.6%0.1%0.4 $2.04 7/15/202414,100 shares $31.02 thousand +147.4%0.2%0.7 $2.20 6/30/20245,700 shares $12.08 thousand +9.6%0.1%0.2 $2.12 6/15/20245,200 shares $12.84 thousand -66.7%0.1%0.2 $2.47 5/31/202415,600 shares $36.97 thousand -6.0%0.3%0.5 $2.37 5/15/202416,600 shares $36.69 thousand -35.7%0.3%0.2 $2.21 4/30/202425,800 shares $55.99 thousand -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228.43 thousand -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224.22 thousand +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185.88 thousand +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73.70 thousand +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29.93 thousand +18.6%0.3%1.8 $1.74 1/31/202414,500 shares $23.93 thousand -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33.86 thousand -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36.08 thousand -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44.75 thousand -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52.43 thousand +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42.02 thousand +64.7%0.3%1 $2.20Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. 10/31/202311,600 shares $26.45 thousand -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30.72 thousand -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38.57 thousand -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69.29 thousand -9.3%0.4%1 $3.38 8/31/202322,600 shares $64.86 thousand -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104.61 thousand +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44.92 thousand +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31.73 thousand -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32.47 thousand -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46.45 thousand -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43.85 thousand -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56.16 thousand -51.4%0.5%1 $2.08 4/30/202355,600 shares $145.06 thousand +159.8%1.0%2 $2.61 4/15/202321,400 shares $41.73 thousand -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43.66 thousand -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41.04 thousand +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45.15 thousand -21.3%0.5%1 $1.75 2/15/202332,800 shares $58.71 thousand -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69.21 thousand +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61.45 thousand -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77.87 thousand -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195 thousand +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30.42 thousand -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30.28 thousand +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30.38 thousand +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27.36 thousand -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38.45 thousand -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61.10 thousand -8.1%0.5%0.9 $2.68 8/31/202224,800 shares $62.50 thousand -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105.27 thousand -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163.30 thousand -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256.41 thousand +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134.15 thousand -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200.48 thousand -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460.71 thousand +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67.46 thousand -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129.21 thousand -14.7%0.8%1 $2.93 4/15/202251,700 shares $177.33 thousand -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252.40 thousand -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289.97 thousand +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313.50 thousand +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351 thousand -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531.93 thousand +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547.54 thousand +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229.71 thousand No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 29,900 shares of INDP short. 5.22% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.22% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 29,900 shares, a decline of 96.0% from the previous total of 748,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 570,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 572,700 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 5.22% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Indaptus Therapeutics: Moleculin Biotech, Inc. (15.64%), Tempest Therapeutics, Inc. (9.67%), Cingulate Inc. (4.75%), Dare Bioscience, Inc. (0.54%), Pulmatrix, Inc. (0.46%), CytoMed Therapeutics Limited (1.42%), Elevation Oncology, Inc. (3.92%), Aytu BioPharma Inc. (9.12%), Lisata Therapeutics, Inc. (0.46%), Natural Alternatives International, Inc. (0.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies MBRX Short Interest Data TPST Short Interest Data CING Short Interest Data DARE Short Interest Data PULM Short Interest Data GDTC Short Interest Data ELEV Short Interest Data AYTU Short Interest Data LSTA Short Interest Data NAII Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDP Stock Alerts